The global allergy diagnostics and therapeutics market size
is expected to reach USD 51.95 billion by 2026 registering a CAGR of 6.3%,
according to a new study by Grand View Research, Inc. Increasing prevalence of
allergic conditions coupled with adoption of immunoassay as diagnostic test is
expected to serve this market with lucrative growth opportunities. According to
the report published by the World Allergy Journal in May 2014, around 300
million cases of asthma and 200 to 250 million cases of food allergies were
reported. This number is expected to increase over the forecast period due to
sedentary lifestyle and poor dietary habits.
Rising industrial pollution, rapid
urbanization in developing countries, and increasing Greenhouse Gas (GHG)
concentrations are expected to result in increased prevalence of pollen induced
respiratory disorder, thereby boosting the overall market growth over the
forecast period. Emergence of technologically advanced products, such as MeDALL
allergen-chip for allergy determination, is further expected to propel the
market growth in the years to come.
The global market is highly
competitive and is led by companies including Thermo Fisher Scientific, Omega
Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics,
bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical, and
Hitachi Chemical Diagnostics. Most of the industry participants focus on the
development of advanced products and technologies to gain competitive
advantage. For instance, in March 2015, Stallergenes received approval for STG
320 in Japan, which is the first sublingual immunotherapy tablet used in the
treatment of house dust mite allergy.
Browse full research report on Allergy Diagnostics And
Therapeutics Market: https://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market
Further key findings from the study suggest:
- Instruments product segment is anticipated to witness the
highest CAGR of 12.2% from 2019 to 2025 due to high demand for analyzers and
laminators for allergy diagnostics
- In vitro is expected to be the largest as well as
fastest-growing test segment over the estimated period on account of
rising demand for minimally invasive and allergen-specific tests
- Antihistamines drug class led the allergy diagnostics and
therapeutics market in 2018 due to its advantages, such as non sedating
nature and minimum side effects with use of second generation
antihistamines in allergy treatment
- Immunotherapy vaccines is expected to register the maximum
CAGR from 2019 to 2025 owing to extensive R&D in the field and advent
of sublingual immunotherapy tablets in the treatment of allergic rhinitis
- For instance, in April 2014, the U.S. FDA approved a
five-grass pollen sublingual tablet (Ex-Oralair) by Stallergenes, which is
used in the treatment of pollen allergy
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market/request/rs1
Grand View Research has segmented the global allergy diagnostics
and therapeutics market on the basis of product, allergen type, end use,
diagnostic test, drug class, and region:
Allergy Diagnostics Product Outlook (Revenue, USD Million,
2014 - 2026)
- Instruments
- Consumables
- Services
Allergy Diagnostics Allergen Type Outlook (Revenue, USD Million,
2014 - 2026)
- Food
- Inhaled
- Drug
- Other
Allergy Diagnostics End Use Outlook (Revenue, USD Million, 2014 -
2026)
- Diagnostic
Laboratories
- Hospitals
- Academic
Research Institutes
Allergy Diagnostics Test Outlook (Revenue, USD Million, 2014 -
2026)
- In
Vivo Test
- Skin
Prick Test
- Intradermal
Test
- Patch
Test
- In
Vitro Test
Allergy Therapeutics Drug Class Outlook (Revenue, USD Million,
2014 - 2026)
- Antihistamines
- Decongestants
- Corticosteroids
- Mast
Cell Stabilizers
- Leukotriene
Inhibitors
- Nasal
Anticholinergics
- Immunomodulators
- Autoinjectable
Epinephrine
- Immunotherapy
Allergy Diagnostics Regional Outlook (Revenue, USD Million, 2014 -
2026)
- North
America
- U.S
- Canada
- Europe
- U.K.
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- MEA
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
No comments:
Post a Comment